View Author
patient sample peptide protein cancer glioma study tumor group number analysis expression table control disease identi vessel result treatment masse blood mutation tissue cluster value intensity level maldi-tof symptom method brain adherence fluid difference cerebrospinal fl uid fication proteomic loss r 132h spectra antibody antigen count cerebrospinal comparison netherland fl ow cytometry syndrome concentration peptide masses differentially cytometry measurement survival j pain symptom figure detection odiii research idh 1 mutations sclerosis erasmu management identi fied paraneoplastic response non-p.r 132h mutations medication cancer pain management progression article neurol accuracy complication ependymoma range diagnosis spectrometry matrix cancer pain correlation
10 Most Recent Publications
|
Elevated numbers of regulatory T cells, central memory T cells and class-switched B cells in cerebrospinal fluid of patients with anti-Hu antibody associated paraneoplastic neurological syndromes
(Article)
Jongste, A.H.C. de Graaf, M.T. de Broek, P.D.M. van den Kraan, J. Smitt, P.A. Gratama, J-W. |
2013-04-08
|
|
Multiplex serology of paraneoplastic antineuronal antibodies
(Article)
Maat, P. Brouwer, E. Hulsenboom, E. Duijn, M.M. van Schreurs, M.W.J. Hooijkaas, H. Smitt, P.A. |
2013-03-21
|
|
Flow cytometric characterization of cerebrospinal fluid cells
(Article)
Graaf, M.T. de Jongste, A.H.C. de Kraan, J. Boonstra, J.G. Smitt, P.A. Gratama, J-W. |
2011-09-01
|
|
First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: Molecular characteristics in relation to response
(Article)
Taal, W. Dubbink, H.J. Heuvel, I. van Holt, B. van der Bromberg, J.E.C. Smitt, P.A. Dinjens, W.N.M. Bent, M.J. van den Zonnenberg, B.A. Postma, T.J. Gijtenbeek, J. Boogerd, W. Groenendijk, F.H. Kros, J.M. Kouwenhoven, M.C.M. Marion, R. van |
2011-02-01
|
|
HLA-DQ2+ individuals are susceptible to Hu-Ab associated paraneoplastic neurological syndromes
(Article)
Graaf, M.T. de Beukelaar, J.W.K. de Haasnoot, G.W. Levering, W.H.B.M. Rogemond, V. Didelot, A. Honnorat, J. Gratama, J-W. Smitt, P.A. |
2010-09-01
|
|
Integrated genomic profiling identifies candidate genes implicated in glioma-genesis and a novel LEO1-SLC12A1 fusion gene
(Article)
Bralten, L.B.C. Kloosterhof, N.K. Gravendeel, A.M. Sacchetti, A. Duijm, E. Kros, J.M. Bent, M.J. van den Hoogenraad, C.C. Smitt, P.A. French, P.J. |
2010-06-01
|
|
Evaluation of the new body fluid mode on the Sysmex XE-5000 for counting leukocytes and erythrocytes in cerebrospinal fluid and other body fluids
(Article)
Jonge, R. de Brouwer, R.W. Graaf, M.T. de Luitwieler, R.L. Fleming, C. Frankrijker-Merkestijn, M. de Smitt, P.A. Boonstra, J.G. Lindemans, J. |
2010-05-01
|
|
Segregation of non-p.R132H mutations in IDH1 in distinct molecular subtypes of glioma
(Article)
Gravendeel, A.M. Kloosterhof, N.K. Bent, M.J. van den Smitt, P.A. French, P.J. Bralten, L.B.C. Marion, R. van Dubbink, H.J. Dinjens, W.N.M. Bleeker, F.E. Hoogenraad, C.C. Michiels, E.M.C. Kros, J.M. |
2010-03-01
|
|
Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology
(Article)
Gravendeel, A.M. Kouwenhoven, M.C.M. Moor, B. de Eilers, P.H. Spek, P.J. van der Kros, J.M. Smitt, P.A. Bent, M.J. van den French, P.J. Gevaert, O. Rooi, J.J. de Stubbs, A. Duijm, J.E. Daemen, A. Bleeker, F.E. Bralten, L.B.C. Kloosterhof, N.K. |
2009-12-01
|
|
Acute CNS white matter lesions in patients with inflammatory bowel disease
(Article)
Lau, L. de Vries, J.M. de Woude, C.J. van der Kuipers, E.J. Siepman, D.A.M. Smitt, P.A. Hintzen, R.Q. |
2009-07-17
|